NRF2 is reportedly deregulated in adipose tissue during obesity, and this transcriptional factor modulates the progression of atherosclerosis, inflammation and lipid homeostasis, including other cardiovascular risk factors associated with obesity. Here, NFE2L2 is linked to obesity due to melanocortin 4 receptor deficiency.